ponvory
janssen-cilag international n.v. - ponesimod - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - ponvory is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.
alvesco 40 mikrog/annos inhalaatiosumute, liuos
takeda gmbh - ciclesonidum - inhalaatiosumute, liuos - 40 mikrog/annos - siklesonidi
alvesco 80 mikrog/annos inhalaatiosumute, liuos
covis pharma europe b.v. - ciclesonide - inhalaatiosumute, liuos - 80 mikrog/annos - siklesonidi
alvesco 160 mikrog/annos inhalaatiosumute, liuos
covis pharma europe b.v. - ciclesonide - inhalaatiosumute, liuos - 160 mikrog/annos - siklesonidi
symbicort 160 mikrog / 4.5 mikrog / inhalaatio inhalaatiosumute, suspensio
astrazeneca oy - budesonide, formoterol fumarate dihydrate - inhalaatiosumute, suspensio - 160 mikrog / 4.5 mikrog / inhalaatio - formoteroli ja budesonidi